PHARMIDABLE
ActiveSummary
The computed 12-month bankruptcy probability of PHARMIDABLE is 3.7% (moderate). The 2024 annual accounts show equity of €31,742 and a net result of -€28,258. Its solvency ranks better than 25% of 25,595 sector peers (NACE 47, financial year 2024). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.